VENUSREM vs WANBURY: Stock Comparison

VENUSREM vs WANBURYUpdated 12 Jun 26, 4:08 PM ISTNSE & company filings

VENUSREM is the larger company by market capitalisation. VENUSREM shows a higher dividend yield, faster revenue growth and lower leverage, while WANBURY shows a lower P/E, a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

VENUSREM leads 8; WANBURY leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

VENUSREMWANBURY

Valuation lens

What price are you paying?

Market CapContext only
₹2,174 Cr
₹832 Cr
P/E RatioWANBURY has the lower reading
18.62x
0x
P/B RatioWANBURY has the lower reading
3.26x
0x
EPSVENUSREM has the higher reading
₹17.18
₹0.93
Book ValueContext only
₹496.56
₹41.34
Dividend YieldVENUSREM has the higher reading
0.61%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
VENUSREM is the larger company
₹2,174 Cr vs ₹832 Cr
P/E Ratio
WANBURY has a lower P/E
0x vs 18.62x
P/B Ratio
WANBURY has a lower P/B
0x vs 3.26x
EPS
VENUSREM has higher earnings per share
₹17.18 vs ₹0.93
Dividend Yield
VENUSREM has a higher dividend yield
0.61% vs 0%
Revenue Growth (TTM YoY)
VENUSREM has faster revenue growth
33% vs -19.2%
EPS Growth (TTM YoY)
VENUSREM has faster EPS growth
126.4% vs 0%
Qtr Sales Growth
WANBURY has stronger quarterly sales growth
0.61% vs 0.03%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricVENUSREMWANBURY
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricVENUSREMWANBURY
Live Price₹1,797.5₹239.35
Day Change4.8%-0.87%
Volume2.46 L59,568
52-Week High₹1,800.8₹358.85
52-Week Low₹424₹161.5
Distance from 52W High-0.18%-33.3%

Valuation

MetricVENUSREMWANBURY
Market Cap₹2,174 Cr₹832 Cr
P/E Ratio18.62x0x
P/B Ratio3.26x0x
EPS₹17.18₹0.93
Book Value₹496.56₹41.34
Dividend Yield0.61%0%

Growth

MetricVENUSREMWANBURY
Revenue Growth (TTM YoY)33%-19.2%
EPS Growth (TTM YoY)126.4%0%
Qtr Sales Growth0.03%0.61%
Qtr Profit Growth-10.03%-85.06%

Profitability & Leverage

MetricVENUSREMWANBURY
ROE14.4%45.78%
ROCE14.81%25.06%
Net Margin13.35%10.17%
Operating Margin17.12%13.81%
Debt to Equity0x1.49x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricVENUSREMWANBURY
Promoter Holding41.76%34.36%
FII Holding2.92% 0.12 pp0.89% 0.3 pp
DII Holding0.89% 0.31 pp0.06% 0.06 pp
Public Holding54.43% 0.19 pp56.03% 0.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: VENUSREM and WANBURY.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.